Alnylam Pharmaceuticals, Inc.
COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE
Last updated:
Abstract:
The invention relates to antisense polynucleotide agents targeting the LECT2 gene, and methods of using such anti sense polynucleotide agents to inhibit expression of LECT2 and to treat subjects having a LECT2-associated disease, e.g., amyloidosis.
Status:
Application
Type:
Utility
Filling date:
13 Jul 2020
Issue date:
1 Apr 2021